Skip to content

Clinical trials

Phase 1/2 Leukemia, Mast-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Mast-Cell Phase: Phase 1/2 Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20091
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center1
Fred Hutchinson Cancer Center1
GT Biopharma, Inc.1
M.D. Anderson Cancer Center1
UNC Lineberger Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Mast-Cell5
Leukemia, Myeloid, Acute5
Burkitt Lymphoma4
Hodgkin Disease4
Immunoblastic Lymphadenopathy4
Intraocular Lymphoma4
Leukemia, Hairy Cell4
Leukemia, Large Granular Lymphocytic4
Leukemia, Lymphocytic, Chronic, B-Cell4
Leukemia, Myelomonocytic, Chronic4

Trials

Showing 51 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.